Graduate School Alumni

More than 350 expected graduates – 104 medical doctors, 86 with doctorates and 190 with Master of Science degrees – in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.

Dr. Cheryl Dreyfus, a distinguished professor and chair of the Department of Neuroscience and Cell Biology at Rutgers-Robert Wood Johnson Medical School, has been awarded the 2023 Weill Cornell Graduate School Alumni Award of Distinction.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2023 for their academic achievements.

 The program's enduring goal during the past half century has been to create the next generation of leaders in biomedical research.

The award recognizes alumni for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to society.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2022 for their academic achievements on May 18.

Weill Cornell Medicine honored a dozen faculty, trainees, students and staff April 25 for their outstanding service and leadership in promoting diversity at the academic medical institution.

Nursing homes acquired by private equity companies saw an increase in emergency room visits and hospitalizations among long-stay residents and an uptick in Medicare costs, according to a new study from Weill Cornell Medicine investigators. 

On Aug. 20, 106 students in Weill Cornell Medical College’s Class of 2025 received their short white coats during an outdoor, in-person White Coat Ceremony. 

Weill Cornell Medicine’s Office of Diversity and Inclusion has been recognized as a Diversity Champion by Crain’s New York Business as part of its first annual Excellence in Diversity and Inclusion Awards, announced July 15.

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.

Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

Dr. Barbara Hempstead, dean of the Weill Cornell Graduate School of Medical Sciences, has been awarded Weill Cornell Medicine’s Joan and Sanford I. Weill Exemplary Achievement Award.

Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.

A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision. 

A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.

More than 80 Weill Cornell Medicine students, faculty and senior leadership gathered Oct. 7 at Weill Cornell Medicine for a ribbon-cutting ceremony for the Feil Family Student Center, which occupies renovated first and second floors in the main campus buildings on York Avenue. The state-of-the-art center was made possible by a $12.5 million gift from the Feil Family.

Weill Cornell Medicine hosted the first-ever National Conference on Medical Student Mental Health and Well-Being  Sept. 18-19, in partnership with the Association of American Medical Colleges, Associated Medical Schools of New York and the American Foundation for Suicide Prevention,  

Medical conditions and health habits that affect blood flow in the brain—or cerebrovascular risk factors—are associated with a subsequent diagnosis of Parkinson’s disease, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian investigators.

Chemical modifications that appear on some RNA transcripts may have evolved in part to help cells repair themselves after damage, and may also be a key to understanding important human diseases, according to new research from scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.